Lundbeckfond Ventures (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:
Copenhagen
Average round investment:
39.42M USD

Lundbeckfond Ventures is an evergreen life science venture fund investing in life science companies primarily in Europe, up to €50 million annualy.

Lundbeckfonden Ventures aims to support the group's activities and operating independently from the Lundbeckfonden’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

We tracked 11 Nordic investments.

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Lundbeckfond Ventures investments breakdown analysis:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Lundbeckfond Ventures mostly invests with:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Investors with similar profile to Lundbeckfond Ventures:

InvestorCriteria
Denmark Sunstone Life Science Ventures
75%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Denmark Novo A/S
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.1
Sofinnova Partners
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.6
Denmark Novo Seeds
70%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 3.2
France Idinvest Partners
69%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 3.8
France Kurma Life Science Partners
68%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.5
Sweden HealthCap
63%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Seventure Partners
62%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.7
Switzerland Novartis Venture Fund
56%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Netherlands LSP (Life Sciences Partners)
54%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes

News about Lundbeckfond Ventures

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)